Skip to main content
Clinical Trials/CTRI/2024/04/065471
CTRI/2024/04/065471Not yet recruitingNot Applicable

Estimate the time to blood culture positivity in neonates with sepsis a observational study

Indira gandhi institute of child health bengaluru1 site in 1 country150 target enrollmentStarted: April 20, 2024Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
150
Locations
1
Primary Endpoint
The primary out come is to estimate the mean time to blood culture positivity in neonatal sepsis.

Study Overview

Brief Summary

NEONATAL SEPSIS STANDS AS A SIGNIFICANT CONTRIBUTOR TO MORTALITY AND LONG TERM COMPLICATIONS IN BOTH DEVELOPED AND DEVELOPING COUNTRIES IT RANKS THE SECOND MAJOR CAUSE OF NEONATAL MORTALITY CLAIMING OVER A MILLION LIVES ANNUALLY ,WHILE CULTURE REMAINS THE GOLD STANDARD FOR DIAGNOSIS  ITS POSITIVITY RATES ARE NOTABLY LOW AND VARIABLE RANGING FROM 10 TO 15 % EARLY IDENTIFICATION OF INFECTING ORGANISM IN THE BLOOD IS CRUCIAL FOR OPTIMIZING ANTIBACTERIAL TREATMENT . TIME TO POSITIVITY PROVIDES INDIRECT INFORMATION ON THE BIOMASS REFLECTING THE BACTERAEMIA LOAD AND MICROBIAL GROWTH RATE A LOWER TIME TO POSITIVITY INDICATES A FASTER POSITVE SIGNAL SUGGEST A HIGHER INOCULUM IN THE BLOOD AND / OR A FASTER GROWTH RATE.

THE AIM OF  STUDY IS TO ESTIMATE THE IMPORTANCE OF TIME TO POSITIVITY AS A CRITICAL FACTOR INFLUENCING DECISION ABOUT ANTIBIOTIC TREATMENT AND ITS DURATION IN CHILDREN WITH SEPSIS

Study Design

Study Type
Observational

Eligibility Criteria

Ages
0.00 Day(s) to 28.00 Day(s) (—)
Sex
All

Inclusion Criteria

  • Neonates less than 28 days.
  • Clinical sepsis.
  • Parents or guardians who has given voluntary signed written and informed consent.

Exclusion Criteria

  • Presence of central line or PICC peripherally inserted central catheter line.
  • Major congenital malformation.

Outcomes

Primary Outcomes

The primary out come is to estimate the mean time to blood culture positivity in neonatal sepsis.

Time Frame: Any time before discharge

Secondary Outcomes

  • Type of sepsis(Before Discharge)
  • Sepsis markers like CRP & Procalcitonin(Before Discharge)
  • Organism profile(Before Discharge)
  • Shock(Before Discharge)
  • Duration of hospital stay(Before Discharge)
  • Mortality(Before Discharge)

Investigators

Sponsor
Indira gandhi institute of child health bengaluru
Sponsor Class
Government medical college
Responsible Party
Principal Investigator
Principal Investigator

Dr Murali M

Indira Gandhi Institute of Child Health, Bengaluru

Study Sites (1)

Loading locations...

Similar Trials

To study the value of blood culture... | Clinical Trial